文献速递小儿眼科与斜弱视神经眼科

弱视的全基因组与罕见变异关联研究:美国混血与非洲裔人群

Genome-Wide and Rare Variant Association Studies of Amblyopia in Admixed American and African Ancestry Groups.
PubMed 文献 · Ophthalmology · 2026-07-27

结果显示两族群遗传风险架构不同,但均汇聚于神经发育信号、皮层突触组装和敏感期可塑性,而非眼球结构动力学。

要点

  • AMR GWAS发现245个SNP映射97个位点,涉及ROBO1、SEMA4B、PTPRD、NRXN1、CAMK2D等神经发育和轴突导向基因。
  • AFR GWAS仅发现11个显著变异对应6个位点,主要映射长链非编码RNA和假基因。
  • AMR RVAS识别15个基因包括KIF1B、KIF7、EGF、ERBIN、AKAP17A;AFR RVAS仅识别DLG2基因。

核心结论

  • 弱视遗传风险架构在不同祖先间存在差异,但根本汇聚于神经发育信号、皮层突触组装和敏感期可塑性。

研究设计与样本

  • 回顾性 ancestry 分层 GWAS 和基因水平 RVAS,纳入 All of Us 项目中有全基因组测序的 AFR 和 AMR 参与者。
  • 分层逻辑回归模型调整年龄、生物学性别和基因组祖先前10个主成分。

主要发现

  • AMR GWAS 识别245个独特SNP映射至97个不同位点,包括ROBO1、SEMA4B、PTPRD、NRXN1和CAMK2D。
  • AFR GWAS 识别11个显著变异对应6个位点,主要映射长链非编码RNA和假基因。
  • AMR RVAS 识别15个基因,包括轴突运输基因KIF1B和KIF7以及生长因子信号基因EGF、ERBIN和AKAP17A。
  • AFR RVAS 识别单个基因DLG2,编码突触后蛋白PSD-93,促进儿童早期视觉神经可塑性敏感期关闭。

关键数值与推荐

  • GWAS中SNP达到全基因组显著性标准为P < 5e-8。
  • RVAS中基因与弱视显著关联标准为P < 8.0 × 10-4。
  • GWAS仅限常见变异(次要等位基因频率≥1%)。
  • RVAS仅限编码序列改变效应的罕见变异(次要等位基因频率>1%,仅外显子,排除同义变异),使用SKAT算法在基因水平聚合。

临床怎么用

  • 提示弱视遗传基础涉及神经发育和突触可塑性通路,支持敏感期干预的生物学合理性。
  • 不同祖先人群的弱视遗传架构存在差异,未来遗传风险评分或机制研究需考虑祖先分层。

局限性

  • 病例定义依赖电子健康记录诊断编码,可能存在错分。
  • AFR和AMR亚组病例数相对较少(269例和366例),可能限制罕见变异和弱效应位点的检出。
  • 研究结果基于All of Us项目参与者,外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify genetic variants associated with amblyopia in African (AFR) and Admixed American (AMR) ancestry groups, expanding on previous studies conducted in European ancestry. DESIGN: Retrospective ancestry-stratified genome-wide association study (GWAS) and gene-level rare variant association study (RVAS). PARTICIPANTS: Participants in the All of Us Research Program from AFR and AMR ancestry groups who had whole-genome sequencing available. Cases and controls were distinguished based on the presence of International Classification of Diseases 9/10/SNOMED diagnosis codes for amblyopia in electronic health records. This yielded ancestry-stratified subsets of 269 cases and 71 585 controls of AMR ancestry and 366 cases and 79 460 controls of AFR ancestry. METHODS: Stratified logistic regression models were adjusted for age, biological sex, and the top 10 principal components of genomic ancestry. GWAS was limited to common variants (minor allele frequency ≥1%), and RVAS was limited to rare variants with coding sequence-altering effects (minor allele frequency >1%, exonic only, excluding synonymous variants) aggregated at the gene level using the SKAT algorithm. Downstream analyses of the significant variants were performed using KEGG and GO pathway analysis and STRING database queries for protein-protein interactions and gene-gene interactions. MAIN OUTCOME MEASURES: Single-nucleotide polymorphisms were determined to have genome-wide significance if P < 5e-8 in the GWAS, and genes were determined to have significant association with amblyopia in the RVAS if P < 8.0 × 10-4. RESULTS: In the AMR GWAS, 245 unique single-nucleotide polymorphisms mapping to 97 distinct loci were identified, notably within neurodevelopmental and axonal guidance genes, including ROBO1, SEMA4B, PTPRD, NRXN1, and CAMK2D. The AFR GWAS identified 11 significant variants corresponding to 6 loci mapping primarily to long noncoding RNAs and pseudogenes. The AMR RVAS identified 15 genes, including axonal transport genes (KIF1B and KIF7) and growth factor signaling genes (EGF, ERBIN, and AKAP17A). The AFR RVAS identified a single gene, DLG2, which encodes the postsynaptic protein PSD-93, which promotes the closure of the sensitive period of neuroplasticity for vision in early childhood. CONCLUSIONS: Genetic risk architectures for amblyopia differ across ancestries but fundamentally converge on neurodevelopmental signaling, cortical synapse assembly, and sensitive period plasticity rather than ocular structural dynamics. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any materials discussed in this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Lee KAV, Whitman MC. Genome-Wide and Rare Variant Association Studies of Amblyopia in Admixed American and African Ancestry Groups. Ophthalmology. 2026. PMID: 42508771. doi:10.1016/j.ophtha.2026.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。